Immune Design
Seattle
About Immune Design
Immune Design Corp. (IDC) uses breakthrough technology to develop safe and effective vaccines and therapeutics, with emphasis on the prevention and treatment of infectious disease. This goal is being achieved through dedicated research aimed towards a greater understanding of the immune system, and by developing a new generation of immune-based products for the pharmaceutical industry. IDC is passionate about its mission to alleviate human suffering and pursues this goal with high energy and an unsurpassed standard of excellence
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $228.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jul 2017)
- Ticker: nasdaq:IMDZ
- Website: immunedesign.com
- Phone: +1 206-682-0645
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immune-design-219064 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.